Cited by 119Treatment of Major DepressionPsychotherapy Techniques and ApplicationsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

EFFICACY AND ACCEPTABILITY OF ACUTE TREATMENTS FOR PERSISTENT DEPRESSIVE DISORDER: A NETWORK META-ANALYSIS

Open access
Kriston, Levente, von Wolff, Alessa, Westphal, Annika, Hölzel, Lars P., Härter, Martin·2014·Depression and Anxiety

Abstract

BACKGROUND: We aimed to synthesize the available evidence on the relative efficacy and acceptability of specific treatments for persistent depressive disorder. METHODS: We searched several databases up to January 2013 and included randomized controlled trials that compared acute pharmacological, psychotherapeutic, and combined interventions with each other or placebo. The outcome measures were the proportion of patients who responded to (efficacy) or dropped out from (acceptability) the allocated treatment. Data synthesis was performed with network meta-analysis. RESULTS: A network of 45 trials that tested 28 drugs included data from 5,806 and 5,348 patients concerning efficacy and acceptability, respectively. A second network of 15 trials that tested five psychotherapeutic and five combined interventions included data from 2,657 and 2,719 patients concerning efficacy and acceptability, respectively. Among sufficiently tested treatments, fluoxetine (odds ratio (OR) 2.94), paroxetine (3.79), sertraline (4.47), moclobemide (6.98), imipramine (4.53), ritanserin (2.35), amisulpride (5.63), and acetyl-l-carnitine (5.67) were significantly more effective than placebo. Pairwise comparisons showed advantages of moclobemide (2.38) and amisulpride (1.92) over fluoxetine. Sertraline (0.57) and amisulpride (0.53) showed a lower dropout rate than imipramine. Interpersonal psychotherapy with medication outperformed medication alone in chronic major depression but not in dysthymia. Evidence on cognitive behavioral analysis system of psychotherapy plus medication was partly inconclusive. Interpersonal psychotherapy was less effective than medication (0.48) and cognitive behavioral analysis system of psychotherapy (0.45). Several other treatments were tested in single studies. CONCLUSIONS: Several evidence-based acute pharmacological, psychotherapeutic, and combined treatments for persistent depressive disorder are available with significant differences between them.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/da.22236

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In persistent depressive disorder (PDD), medication treatment or combination of medication with psychological treatment provides more benefit than psychological treatment alone.

    “In persistent depressive disorder (PDD), medication treatment or combination of medication with psychological treatment provides more benefit than psychological treatment alone.12,13”

    From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [13]

    The Efficacy and Acceptability of Psychotherapeutic and Combined Treatments section (page not provided) reports that medication was more effective than interpersonal psychotherapy (IPT) alone, and that IPT plus medication was more effective than medication alone at borderline significance. But it found no significant efficacy difference between medication and CBASP, with or without medication. The claim overgeneralizes these treatment-specific findings to psychological treatment alone across PDD. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. [9]9. Härter M, Klesse C, Bermejo I, Schneider F, Berger M. Unipo- lar depression. Diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline. Dtsch Arztebl Int 2010;107:700-708.
  2. [40]40. Fulgente T, Onofrj M, Del Re ML, et al. Laevo-acetylcarnitine (Nicetile R ) treatment of senile depression. Clin Trials J 1990;27:155-163.
  3. [44]44. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al. Cognitive be- havioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry 2009;66:1178-1188.

Cited by

Sorted by citations

Authors
Kriston, L., von Wolff, A., Westphal, A., Hölzel, L. P., & Härter, M.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • Department of Medical Psychology; University Medical Center Hamburg-Eppendorf; Hamburg Germany
  • University Medical Center Freiburg (DE)
Corresponding author
Kriston, Levente
Venue
Depression and Anxiety
Published
2014-01-21
Volume
31
Issue
8
Pages
621-630
ISSN
1091-4269 (ISSN-L)
OpenAlex
W2166833641
Cited by
119
References
51
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 12 · 2020: 11 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 15 · 2015: 13 · 2014: 5
FWCI
2.05
Type
journal article
Language
en
Open access
Locations
  • Depression and Anxiety (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Funders
German Ministry of Education and Research (01KG0923)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
dysthymia, acute treatment, treatment efficacy, treatment acceptability, dropout, antidepressants, moclobemide, amisulpride, fluoxetine, paroxetine, sertraline, imipramine, interpersonal psychotherapy, CBASP
MeSH terms
Humans, Patient Compliance, Treatment Outcome, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review